ANTI-TRANSFERRIN RECEPTOR (TFR) SINGLE CHAIN ANTIBODY FRAGMENT (SCFV): UPDATED RESULTS

Senzer N, Nemunaitis J, Bedell C, Nunan R, Allen H, Sleer L, Chang E. Phase I Safety and Pharmacokintetic Study of Systemic p53 Gene Therapy (SGT-53) using Immunopoplexes Targeted by Anti-Transferrin Receptor (TfR) Single Chain Antibody Fragment (scFv): Updated Results. Poster #536. ASGCT 13th Annual Meeting, May 17 – 22, 2010, Washington, D.C.